HIKMA. Trademark

Trademark Overview


On Monday, December 9, 2019, a trademark application was filed for HIKMA. with the United States Patent and Trademark Office. The USPTO has given the HIKMA. trademark a serial number of 88720317. The federal status of this trademark filing is REGISTERED as of Tuesday, February 1, 2022. This trademark is owned by HIKMA PHARMACEUTICALS PLC. The HIKMA. trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and medicinal preparations and substances, namely, systemic anti-infectives, pharmaceutical and medicinal substances for the prevention, curing, and treatment of viral, metabolic, alimentary, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, parasitic, psychiatric, and immune system related diseases and disorders; pharmaceutical and medicinal substances for the prevention, curing, and treatment of allergies, inflammation, pain, infectious diseases, blood diseases and disorders, nervous system diseases and disorders, malignant neoplastic diseases and disorders, and immunomodulating agent diseases and disorders; chemical preparations for pharmaceutical or medical purposes, namely, for viral, metabolic, alimentary, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncologica...
hikma.

General Information


Serial Number88720317
Word MarkHIKMA.
Filing DateMonday, December 9, 2019
Status700 - REGISTERED
Status DateTuesday, February 1, 2022
Registration Number6634245
Registration DateTuesday, February 1, 2022
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, March 30, 2021

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of "HIKMA." in stylized script.
Goods and ServicesPharmaceutical and medicinal preparations and substances, namely, systemic anti-infectives, pharmaceutical and medicinal substances for the prevention, curing, and treatment of viral, metabolic, alimentary, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, parasitic, psychiatric, and immune system related diseases and disorders; pharmaceutical and medicinal substances for the prevention, curing, and treatment of allergies, inflammation, pain, infectious diseases, blood diseases and disorders, nervous system diseases and disorders, malignant neoplastic diseases and disorders, and immunomodulating agent diseases and disorders; chemical preparations for pharmaceutical or medical purposes, namely, for viral, metabolic, alimentary, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, parasitic, psychiatric, and immune system related diseases and disorders, allergies, inflammation, pain, infectious diseases, blood diseases and disorders, nervous system diseases and disorders, malignant neoplastic diseases and disorders, and immunomodulating agent diseases and disorders
Translation of Words in MarkThe English translation of "HIKMA" in the mark is "wisdom".

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 12, 2019
Primary Code005
First Use Anywhere DateFriday, November 9, 2018
First Use In Commerce DateFriday, November 9, 2018

Trademark Owner History


Party NameHIKMA PHARMACEUTICALS PLC
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressLondon W1S2HR
GB

Party NameHIKMA PHARMACEUTICALS PLC
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLondon W1S2HR
GB

Party NameHIKMA PHARMACEUTICALS PLC
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLondon W1S2HR
GB

Trademark Events


Event DateEvent Description
Tuesday, February 1, 2022REGISTERED-PRINCIPAL REGISTER
Wednesday, December 29, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, December 28, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, December 21, 2021STATEMENT OF USE PROCESSING COMPLETE
Tuesday, November 23, 2021USE AMENDMENT FILED
Friday, December 17, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 23, 2021TEAS STATEMENT OF USE RECEIVED
Monday, August 16, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, August 16, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 16, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 16, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 16, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, May 25, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 30, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 30, 2021PUBLISHED FOR OPPOSITION
Wednesday, March 10, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 2, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 2, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 2, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, February 22, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 22, 2021EXAMINER'S AMENDMENT ENTERED
Monday, February 22, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, February 22, 2021EXAMINERS AMENDMENT E-MAILED
Monday, February 22, 2021EXAMINERS AMENDMENT -WRITTEN
Friday, February 5, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 4, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 4, 2021TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, August 12, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, August 12, 2020FINAL REFUSAL E-MAILED
Wednesday, August 12, 2020FINAL REFUSAL WRITTEN
Monday, July 20, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 20, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 10, 2020ASSIGNED TO LIE
Tuesday, June 30, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 30, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, June 30, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 30, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, June 30, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 30, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 30, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, December 30, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 30, 2019NON-FINAL ACTION E-MAILED
Monday, December 30, 2019NON-FINAL ACTION WRITTEN
Thursday, December 26, 2019ASSIGNED TO EXAMINER
Thursday, December 12, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, December 12, 2019NEW APPLICATION ENTERED IN TRAM